We need to know what CSL is going to do with their buyback. I agree with the $70 are ONLY if they have buyback.
I am in the medical field once was in top 20 shareholding for biota in the old flu days had my broker buy 1 million when they started going at 65 cents. I knew their product and info on New England med journal and working in ED saw the flu coming.
What I now see is hospitals getting better prices and flu vax income dropping +++ for CSL (very sad).
They are priced as growth but I cant see growth in next 3 to 4 years costs increasing markedly because of risk.
